Adm board of directors enhances r&d, innovation expertise with nomination of elanco executive ellen de brabander

Chicago--(business wire)--adm (nyse: adm), a global leader in human and animal nutrition, today announced that its board of directors has nominated elanco executive vice president for innovation and regulatory affairs, dr. ellen de brabander, to stand for election to the board at the company's upcoming annual stockholders' meeting on may 4, 2023.
ADM Ratings Summary
ADM Quant Ranking